These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10494577)

  • 1. Differential effects of withdrawal from chronic amphetamine or fluoxetine administration on brain stimulation reward in the rat--interactions between the two drugs.
    Lin D; Koob GF; Markou A
    Psychopharmacology (Berl); 1999 Aug; 145(3):283-94. PubMed ID: 10494577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats.
    Markou A; Harrison AA; Chevrette J; Hoyer D
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):133-42. PubMed ID: 15452682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Harrison AA; Liem YT; Markou A
    Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats.
    Paterson NE; Myers C; Markou A
    Psychopharmacology (Berl); 2000 Nov; 152(4):440-6. PubMed ID: 11140337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic fluoxetine treatment decreases the sensitivity of rats to rewarding brain stimulation.
    Lee K; Kornetsky C
    Pharmacol Biochem Behav; 1998 Jun; 60(2):539-44. PubMed ID: 9632238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent alterations in ICSS thresholds associated with repeated amphetamine administrations.
    Lin D; Koob GF; Markou A
    Pharmacol Biochem Behav; 2000 Mar; 65(3):407-17. PubMed ID: 10683480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents.
    Cryan JF; Hoyer D; Markou A
    Biol Psychiatry; 2003 Jul; 54(1):49-58. PubMed ID: 12842308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The triple reuptake inhibitor DOV 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats.
    Prins J; Kenny PJ; Doomernik I; Schreiber R; Olivier B; Mechiel Korte S
    Eur J Pharmacol; 2012 Oct; 693(1-3):51-6. PubMed ID: 23010469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure to chronic mild stress alters thresholds for lateral hypothalamic stimulation reward and subsequent responsiveness to amphetamine.
    Lin D; Bruijnzeel AW; Schmidt P; Markou A
    Neuroscience; 2002; 114(4):925-33. PubMed ID: 12379248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased brain reward produced by ethanol withdrawal.
    Schulteis G; Markou A; Cole M; Koob GF
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5880-4. PubMed ID: 7597046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Psychopharmacology (Berl); 1999 Apr; 143(4):426-32. PubMed ID: 10367561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated electroconvulsive shock attenuates the depressive-like effects of d-amphetamine withdrawal on brain reward function in rats.
    Barr AM; Zis AP; Phillips AG
    Psychopharmacology (Berl); 2002 Jan; 159(2):196-202. PubMed ID: 11862349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent intermittent ethanol exposure diminishes anhedonia during ethanol withdrawal in adulthood.
    Boutros N; Semenova S; Markou A
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):856-64. PubMed ID: 24560005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subchronic fluoxetine treatment induces a transient potentiation of amphetamine-induced hyperlocomotion: possible pharmacokinetic interaction.
    Sills TL; Greenshaw AJ; Baker GB; Fletcher PJ
    Behav Pharmacol; 2000 Apr; 11(2):109-16. PubMed ID: 10877115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice.
    Stoker AK; Markou A
    Behav Brain Res; 2011 Sep; 223(1):176-81. PubMed ID: 21557971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.
    Lazenka MF; Blough BE; Negus SS
    J Sex Med; 2016 Mar; 13(3):338-49. PubMed ID: 26831817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.
    Macey DJ; Koob GF; Markou A
    Brain Res; 2000 Jun; 866(1-2):82-91. PubMed ID: 10825483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
    Todtenkopf MS; O'Neill KS; Kriksciukaite K; Turncliff RZ; Dean RL; Ostrovsky-Day I; Deaver DR
    Addict Biol; 2009 Sep; 14(4):408-18. PubMed ID: 19489752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
    Todtenkopf MS; Marcus JF; Portoghese PS; Carlezon WA
    Psychopharmacology (Berl); 2004 Apr; 172(4):463-70. PubMed ID: 14727002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic stress sensitizes amphetamine-elicited 50-kHz calls in the rat: Dependence on positive affective phenotype and effects of long-term fluoxetine pretreatment.
    Vares M; Metelitsa M; Kõiv K; Kaldmäe M; Laugus K; Tiitsaar K; Shimmo R; Harro J
    Pharmacol Biochem Behav; 2018 Aug; 171():10-19. PubMed ID: 29803856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.